These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37985124)

  • 21. Congenital Myasthenic Syndromes.
    Iyadurai SJP
    Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy-associated respiratory failure in muscle specific kinase congenital myasthenic syndrome.
    Wadwekar V; Pillai RR; Sesh S; Nair SS; Nair M
    Muscle Nerve; 2019 Apr; 59(4):E24-E26. PubMed ID: 30635923
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolated vocal cord paralysis in two siblings with compound heterozygous variants in MUSK: Expanding the phenotypic spectrum.
    Murali C; Li D; Grand K; Hakonarson H; Bhoj E
    Am J Med Genet A; 2019 Apr; 179(4):655-658. PubMed ID: 30719842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital myasthenic syndromes.
    Beeson D
    Handb Clin Neurol; 2024; 203():69-88. PubMed ID: 39174255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital myasthenic syndromes.
    Engel AG
    Handb Clin Neurol; 2008; 91():285-331. PubMed ID: 18631848
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
    Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
    Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
    [No Abstract]   [Full Text] [Related]  

  • 27. Are MuSK antibodies the primary cause of myasthenic symptoms?
    Selcen D; Fukuda T; Shen XM; Engel AG
    Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Overview: MuSK/Dok-7].
    Motomura M; Fukuda T; Yoshimura T; Tsujihata M
    Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
    Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
    Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic, serological and clinical evaluation of childhood myasthenia syndromes- single center subgroup analysis experience in Turkey.
    Özsoy Ö; Cinleti T; Günay Ç; Sarıkaya Uzan G; Giray Bozkaya Ö; Çağlayan AO; Hız Kurul S; Yiş U
    Acta Neurol Belg; 2023 Dec; 123(6):2325-2335. PubMed ID: 37656362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness.
    Owen D; Töpf A; Preethish-Kumar V; Lorenzoni PJ; Vroling B; Scola RH; Dias-Tosta E; Geraldo A; Polavarapu K; Nashi S; Cox D; Evangelista T; Dawson J; Thompson R; Senderek J; Laurie S; Beltran S; Gut M; Gut I; Nalini A; Lochmüller H
    Am J Med Genet A; 2018 Jul; 176(7):1594-1601. PubMed ID: 29704306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands.
    Beeson D; Hantaï D; Lochmüller H; Engel AG
    Neuromuscul Disord; 2005 Jul; 15(7):498-512. PubMed ID: 15951177
    [No Abstract]   [Full Text] [Related]  

  • 33. Congenital myasthenic syndromes: recent advances.
    Beeson D
    Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differential congenital myasthenia syndrome diagnosis].
    Spuler S; Lehmann TN; Engel AG
    Nervenarzt; 2004 Feb; 75(2):141-4. PubMed ID: 14770284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital myasthenic syndrome: Ten years clinical experience from a quaternary care south-Indian hospital.
    Wadwekar V; Nair SS; Tandon V; Kuruvilla A; Nair M
    J Clin Neurosci; 2020 Feb; 72():238-243. PubMed ID: 31889643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic basis and phenotypic features of congenital myasthenic syndromes.
    Engel AG
    Handb Clin Neurol; 2018; 148():565-589. PubMed ID: 29478601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.